Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Kaye

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
World Neurosurgery|August 25, 2022
C1 Lateral Mass Screw Placement Through Endonasal Corridor for Purpose of O-C1 Fusion: Morphometric Analysis in Cadaveric SpecimensJonathan A Forbes, Paolo Palmisciano, Daniel McGough, et al.
Surgical Neurology International|June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature reviewNatalie Ivey, Jeff F Zhang, Abigail Zack, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2016
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorJoel Kaye, Victor Piryatinsky, Tal Birnberg, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
World Neurosurgery|August 25, 2022
C1 Lateral Mass Screw Placement Through Endonasal Corridor for Purpose of O-C1 Fusion: Morphometric Analysis in Cadaveric SpecimensJonathan A Forbes, Paolo Palmisciano, Daniel McGough, et al.
Surgical Neurology International|June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature reviewNatalie Ivey, Jeff F Zhang, Abigail Zack, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2016
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorJoel Kaye, Victor Piryatinsky, Tal Birnberg, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Pageof 4